Stoke Therapeutics enters $85.5M lease for 98,500 sq ft Waltham HQ/lab through 2038

Stoke Therapeutics, Inc.

New lease with NWALP PHOP Property Owner LLC for 98,500 sq ft at 245 Fifth Avenue, Waltham, MA.
Aggregate base rent ~$85.5M over term ending March 31, 2038; two five-year extension options at market rate.
Security deposit of $3M in form of irrevocable standby letter of credit, reducible over time.
Lease supports expansion of corporate headquarters and laboratory space.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Stoke Therapeutics, Inc. entered into Lease Agreement with NWALP PHOP Property Owner LLC valued at approximately 98,500 square feet (effective 2026-01-21).

Action: entry
Agreement: lease
Counterparty: NWALP PHOP Property Owner LLC
Value: approximately 98,500 square feet
Effective: 2026-01-21

Exact text from the filing

On January 21, 2026, Stoke Therapeutics, Inc. (the “Company”) entered into a new lease for its corporate headquarters and laboratory with NWALP PHOP Property Owner LLC, located at 245 Fifth Avenue, Waltham, Massachusetts (the “Lease Agreement”), in order to expand its office and laboratory space.

View on SEC.gov

284 material agreements filed in the last 30 days. Browse all material agreements →

Stoke Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-022569

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.